Connor, Clark & Lunn Investment Management (CC&L)’s CONMED CNMD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,427	Closed	-$708K	–	1576
2025 Q4	$708K	Buy	+17,427	New	+$758K	﹤0.01%	1228
2024 Q2	–	Sell	-56,237	Closed	-$4.5M	–	1424
2024 Q1	$4.5M	Buy	56,237 +34,571	+160%	+$3.08M	0.02%	457
2023 Q4	$2.37M	Buy	21,666 +5,400	+33%	+$558K	0.01%	627
2023 Q3	$1.64M	Sell	16,266 -2,110	-11%	-$242K	0.01%	672
2023 Q2	$2.5M	Buy	+18,376	New	+$2.24M	0.01%	553
2018 Q4	–	Sell	-3,925	Closed	-$311K	–	955
2018 Q3	$311K	Buy	+3,925	New	+$304K	﹤0.01%	781

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CNMD Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of CONMED (CNMD) in Q1 2026, closing a stake of 17,427 shares — an estimated $708K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CNMD in Q3 2018 and held it in 6 quarters. The position peaked at $4.5M in Q1 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 17,427 CONMED shares in Q1 2026, an estimated $708K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CONMED in Q3 2018 and held it in 6 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s CONMED position peaked at $4.5M in Q1 2024.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.